✦ LIBER ✦

Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy

✍ Scribed by John M. Pellock; Michael C. Smith; James C. Cloyd; Basim Uthman; B.J. Wilder

Book ID: 116978443
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 222 KB
Volume: 5
Category: Article
ISSN: 1525-5050
DOI: 10.1016/j.yebeh.2004.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioavailability of a Divalproex Extended

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs

✍ Kenneth W. Sommerville, Dr Sandeep Dutta, Victor Biton, Yiming Zhang, James C. C 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 126 KB

Tramadol extended-release formulations i

Tramadol extended-release formulations in the management of pain due to osteoarthritis

✍ Mongin, Gérald 📂 Article 📅 2007 🏛 Expert Reviews 🌐 English ⚖ 205 KB

Pharmacokinetics of an immediate and ext

Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs

✍ C. L. ARAGON; M. R. READ; J. S. GAYNOR; M. D. BARNHART; D. WILSON; M. G. PAPICH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

The assessment of human regional drug ab

The assessment of human regional drug absorption of free acid and sodium salt forms of Acipimox, in healthy volunteers, to direct modified release formulation strategy

✍ Rajeev Menon; Eugenio Cefali; Ian Wilding; Heather Wray; Alyson Connor 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

PCV81 AN ECONOMIC EVALUATION OF THE ADDI

PCV81 AN ECONOMIC EVALUATION OF THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY IN TERMS OF OPTIMAL LIPID VALUE ATTAINMENT

✍ S Balu; RJ Simko; RT Burge; MJ Cziraky; RA Quimbo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PCV83 AN EVALUATION OF THE INCREMENTAL C

PCV83 AN EVALUATION OF THE INCREMENTAL CHANGE IN THE INCIDENCE OF CARDIOVASCULAR EVENTS AND RELATED COSTS WITH THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY

✍ S Balu; RJ Simko; RT Burge; MJ Cziraky; RA Quimbo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB